Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 2, 2014, Pages 760-767

  Han, Gaohua ^a,b   Tian, Ye ^a   Duan, Bensong ^c,d   Sheng, Haihui ^d   Gao, Hengjun ^c,d   Huang, Junxing ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b TAIZHOU PEOPLE S HOSPITAL   (China)

^c TONGJI UNIVERSITY   (China)

^d National Engineering Center for Biochip at Shanghai   (China)

Author keywords

Annexin A1; Apurinic apyrimidinic endonuclease 1; Esophageal squamous cell carcinoma; Prognosis; Three prime repair exonuclease 1

Indexed keywords

EID: 84894037654     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. He J and Chen W. 2012 Chinese Cancer Registry Annual Report. Military Medical Science Press 2012, pp: 27-31.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous Cell Carcinoma-Similarities and Differences among Anatomical Sites. Am J Cancer Res 2011; 1: 275-300.
4. Calmon MF, Mota MT, Babeto E, Candido NM, Girol AP, Mendiburu CF, Bonilha JL, Silvestre RV, Rosa BM, Thome JA, Medeiros GH, Soares FA, Guimaraes GC, de Arruda JG, Oliani SM, Villa LL, Vassallo J and Rahal P. Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. PLoS One 2013; 8: e53260.
5. Mu D, Gao Z, Guo H, Zhou G and Sun B. Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1. PLoS One 2013; 8: e74922.
6. Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT and Kuo ML. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer 2012; 118: 5757-5767.
7. Kang H, Ko J and Jang SW. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochem Biophys Res Commun 2012; 423: 188-194.
8. Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways. PLoS One 2012; 7: e45510.
9. Jorge YC, Mataruco MM, Araujo LP, Rossi AF, de Oliveira JG, Valsechi MC, Caetano A, Miyazaki K, Fazzio CS, Thome JA, Rahal P, Oliani SM and Silva AE. Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer. Mediators Inflamm 2013; 2013: 152860.
10. Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY and Moon BI. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer 2011; 14: 262-268.
11. Zhu DW, Liu Y, Yang X, Yang CZ, Ma J, Yang X, Qiao JK, Wang LZ, Li J, Zhang CP, Zhang ZY and Zhong LP. Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade. BMC Cancer 2013; 13: 301.
12. Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q and Xie K. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 2008; 25: 695-702.
13. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR and Goodglick L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006; 37: 1583-1591.
14. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR and Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006; 12: 4598-4604.
15. Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li WJ, Wang C, Goldstein AM, Li G, Emmert-Buck MR and Taylor PR. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 6013-6022.
16. Guo C, Liu S and Sun MZ. Potential role of Anxa1 in cancer. Future Oncol 2013; 9: 1773-1793.
17. Xia L, Guan W, Wang D, Zhang YS, Zeng LL, Li ZP, Wang G and Yang ZZ. Killing effect of Ad5/F35-APE1 siRNA recombinant adenovirus in combination with hematoporphrphyrin derivative-mediated photodynamic therapy on human nonsmall cell lung cancer. Biomed Res Int 2013; 2013: 957913.
18. Dai N, Cao XJ, Li MX, Qing Y, Liao L, Lu XF, Zhang SH, Li Z, Yang YX and Wang D. Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer. PLoS One 2013; 8: e58001.
19. Wang CJ, Lam W, Bussom S, Chang HM and Cheng YC. TREX1 acts in degrading damaged DNA from drug-treated tumor cells. DNA Repair (Amst) 2009; 8: 1179-1189.
20. Tomicic MT, Aasland D, Nikolova T, Kaina B and Christmann M. Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs. Biochim Biophys Acta 2013; 1833: 1832-1843.
21. Zhang X, He C, He C, Chen B, Liu Y, Kong M, Wang C, Lin L, Dong Y and Sheng H. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Pathol Res Pract 2013; 209: 510-515.
22. Patton KT, Chen HM, Joseph L and Yang XJ. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 2005; 47: 597-601.
23. Wang LD, Yang YH, Liu Y, Song HT, Zhang LY and Li PL. Decreased expression of annexin A1 during the progression of cervical neoplasia. J Int Med Res 2008; 36: 665-672.
24. Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E and Parente L. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther 2006; 5: 643-647.
25. Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B, Zhou LP, Liu F, Zhang JS, Wang K, Xie YQ, Shao YF and Zhao XH. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10: 1466-1470.
26. Huang J, Hu N, Goldstein AM, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Li G, Giffen C and Taylor PR. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Carcinogenesis 2000; 21: 2019-2026.
27. Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP and Kuo MY. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 2008; 97: 544-550.
28. Wang D, Zhang H, Fang Z and Yu G. Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma. Eur Surg Res 2010; 45: 151-157.
29. Wang LP, Bi J, Yao C, Xu XD, Li XX, Wang SM, Li ZL, Zhang DY, Wang M and Chang GQ. Annexin A1 expression and its prognostic significance in human breast cancer. Neoplasma 2010; 57: 253-259.
30. Li CF, Shen KH, Huang LC, Huang HY, Wang YH and Wu TF. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma. Pathology 2010; 42: 43-49.
31. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T and Barnes DE. Gene-targeted mice lacking the Trex1 (DNase III) 3'→5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 2004; 24: 6719-6727.
32. Dong X, Li Y, Hess KR, Abbruzzese JL and Li D. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. Oncologist 2011; 16: 61-70.
33. Al-Attar A, Gossage L, Fareed KR, Shehata M, Mohammed M, Zaitoun AM, Soomro I, Lobo DN, Abbotts R, Chan S and Madhusudan S. Human apurinic/apyrimidinic endonuclease (AP-E1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. Br J Cancer 2010; 102: 704-709.
34. Fareed KR, Al-Attar A, Soomro IN, Kaye PV, Patel J, Lobo DN, Parsons SL and Madhusudan S. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. Br J Cancer 2010; 102: 1600-1607.